Bortezomib (Bortezomib)

**Product type:** Human Prescription Drug

**Active ingredient:** BORTEZOMIB

**Strength:** 3.5 mg/3.5mL

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Intravenous; Subcutaneous

**Labeler:** Novadoz Pharmaceuticals LLC

**Marketing category:** ANDA (ANDA209622)

**Pharmacologic class:** Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]